Copenhagen   |     |   By invitation only

The power of data: Developing Europe’s next generation of medicines and health technologies

A Science|Business Future-Proofing Medicines high-level roundtable (14:00 – 17:00 CET)

As the EU moves forward with its new pharmaceutical strategy and revising current legislation, it recognises that secure and efficient access to health data is key – both for exploiting the huge potential of new technologies, and for sustaining Europe’s historical excellence in health & life science sectors. In parallel, the Commission has just launched the European Health Data Space (EHDS), which aims to be a game changer in the digitalisation of European health systems, and a vital resource for industry, regulators and other stakeholders in health innovation.

Nonetheless, as the EU rewrites its rule book and standards, important questions remain about how these can anticipate and accommodate the future breakthroughs in medical science, data science and digital technologies which will underpin the next generation of therapeutics and devices. What are the keys to success for harmonising the health data landscape? How to tackle the complex challenge of balancing data quality, security, access and interoperability? In which ways can new methods of evidence generation and assessment – such as analysis of big and real-world data, and AI – be better integrated? And what to do with the vast volumes of medical, genomic and molecular data now available?

On June 27, the Science|Business Future-Proofing Medicines initiative will convene the first in a series of expert dialogues which will explore answers to these issues and more. By gathering best practices and thought leadership at national level, the initiative will look to develop recommendations for “future-proofing” the EU regulatory framework and accelerating the delivery of treatments to patients and citizens.

Against this backdrop, our invitation-only event in Copenhagen will focus on ways in which the exchange of, and access to, health data can be improved, across sectors and borders, to support medicines development and evaluation. In parallel, it will ask what the EU at large can learn from the renowned Danish approach to health data management and use. 



Featured guests
Andrzej Rys
Director, Health Systems, Medical Products & Innovation, DG SANTE, European Commission
Pernille Weiss
Member, European Parliament
Dorte Bech Vizard
Deputy Permanent Secretary, Patient Safety, Medicines and Global Health, Ministry of Health, Government of Denmark
Jesper Kjær
Director of Department, Data Analytics Center (DAC), Danish Medicines Agency
Timo Minssen
Head, CeBIL - Centre for Advanced Studies in Biomedical Innovation Law, University of Copenhagen
Douglas Gregory
Senior Director, EU Government Affairs Strategy & Excellence, Bristol Myers Squibb
Sarah Garner
Senior Policy Advisor, WHO Europe
Nicholson Price
Professor of Law, University of Michigan; Research partner, Centre for Advanced Studies in Biomedical Innovation Law (CeBIL)
Lena Juel Rasmussen
Managing Director, Center for Healthy Ageing, University of Copenhagen
Per Jørgensen
Deputy Director, Rigshospitalet
Allan Luplau
Chief Executive Officer, Danmark Sygeforsikring
Trine Winterø
Vice Dean for Innovation and External Relations, Faculty of Health and Medical Sciences, University of Copenhagen
Katrine Vedel
Chief Advisor, Healthcare Denmark
Niels Christian Ganderup
Senior Investment Manager, HealthTech & Data, Copenhagen Capacity
Clara Hellner
Director, Research and Innovation & Deputy Chair, Region Stockholm Assembly & Stockholm Science City Foundation
Cai Grau
Professor, Department of Oncology and Danish Center for Particle Therapy, Aarhus University Hospital
Per Horn
Business Creation & Innovation Manager, & Regional Manager for Denmark, EIT Health
Anton Ussi
Operations & Finance Director, EATRIS
Anna Nilsson Vindefjärd
Founder and Secretary General, Research!Sweden
Samir Bhatt
Professor, Statistics and Public Health, Faculty of Medicine, School of Public Health, Imperial College London
Kirsten Ohm Kyvik
Head of Department, Department of Clinical Medicine, University of Southern Denmark
Lars Maaløe
Chief Technology Officer, Corti
Christian Fynbo Christiansen
Professor & Consultant, Department of Clinical Epidemiology, Aarhus University
Maria Heilskou Pedersen
EU Senior Advisor, Public Health & Life Sciences, Central Denmark EU Office
Steen Bennike Mortensen
Scientific Investment Officer, Innovation Fund Denmark
Mario Reale
Senior Research Engagement Officer, GÉANT
Heike Scheuerpflug
Head, Research Support Department, University of Luxembourg
Marianne Pilgaard
CEO, Trial Nation
Laura Duus Dahlin
Senior Advisor, The Danish Chamber of Commerce
Practical Information

For further information about this event, please contact Martine Vogt [email protected]